Journal of Ocular Pharmacology and Therapeutics
Publications & Posters
VIEW:
The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.
Investigative Ophthalmology & Visual Science
Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug
Association for Research in Vision and Ophthalmology
QLS-101 In Vivo Systemic and Ocular Toxicology and Pharmacokinetic Profiles
Association for Research in Vision and Ophthalmology
QLS-101 In Vitro Ocular Tissue Conversion and Activity Profile
American Glaucoma Society